Cargando…

Association of glucocorticoid receptor polymorphisms with clinical and metabolic profiles in polycystic ovary syndrome

OBJECTIVES: We aimed to investigate whether glucocorticoid receptor gene polymorphisms are associated with clinical and metabolic profiles in patients with polycystic ovary syndrome. Polycystic ovary syndrome is a complex endocrine disease that affects 5-8% of women and may be associated with metabo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maciel, Gustavo A. Rosa, Moreira, Ricardo P. P., Bugano, Diogo D. G., Hayashida, Sylvia A. Y., Marcondes, José A. M., Gomes, Larissa G., Mendonça, Berenice B., Bachega, Tânia A. S. S., Baracat, Edmund C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2014
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935131/ https://www.ncbi.nlm.nih.gov/pubmed/24626943 http://dx.doi.org/10.6061/clinics/2014(03)06

Ejemplares similares

MON-207 Identification of Monogenic Causes of Polycystic Ovary Syndrome by High Throughput Sequencing
por: Crespo, Raiane, et al.
Publicado: (2019)

Impact of Glucocorticoid Receptor Gene Polymorphisms on the Metabolic Profile of Adult Patients with the Classical Form of 21-Hydroxylase Deficiency
por: Moreira, Ricardo P. P., et al.
Publicado: (2012)

High-throughput Sequencing to Identify Monogenic Etiologies in a Preselected Polycystic Ovary Syndrome Cohort
por: Crespo, Raiane P, et al.
Publicado: (2022)

Influence of the A3669G Glucocorticoid Receptor Gene Polymorphism on the Metabolic Profile of Pediatric Patients with Congenital Adrenal Hyperplasia
por: Moreira, Ricardo P. P., et al.
Publicado: (2014)

The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene
por: Moura-Massari, Vivian Oliveira, et al.
Publicado: (2016)

Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Moreira, Ricardo P. P., et al.
Publicado: (2011)

Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome
por: Baracat, Maria Candida P., et al.
Publicado: (2023)

NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
por: Recuero, Amanda Medeiros, et al.
Publicado: (2022)

An update of genetic basis of PCOS pathogenesis
por: Crespo, Raiane P., et al.
Publicado: (2018)

Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Gomes, Larissa G., et al.
Publicado: (2013)

Evaluation of circulating microRNA profiles in Brazilian women with polycystic ovary syndrome: A preliminary study
por: De Nardo Maffazioli, Giovana, et al.
Publicado: (2022)

Small leucine-rich proteoglycans (SLRPs) in the endometrium of polycystic ovary syndrome women: a pilot study
por: Simões, Ricardo Santos, et al.
Publicado: (2017)

Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization
por: Rocha, Thaís, et al.
Publicado: (2019)

Hypothalamic transcriptional expression of the kisspeptin system and sex steroid receptors differs among polycystic ovary syndrome rat models with different endocrine phenotypes
por: Marcondes, Rodrigo Rodrigues, et al.
Publicado: (2017)

Frequency of genetic polymorphisms of PXR gene in the Brazilian population
por: Moreira, Ricardo P P, et al.
Publicado: (2011)

SUN-359 Preserved Bone Mineral Density In Adults With Classical Forms Of Congenital Adrenal Hyperplasia Submitted To Long-term Low Glucocorticoid Doses
por: Iervolino, Luiz, et al.
Publicado: (2019)

Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia
por: Lousada, Lia Mesquita, et al.
Publicado: (2021)

SUN-361 Reproductive Outcomes in Females with Virilizing Forms of Congenital Adrenal Hyperplasia
por: Falcao, Camila, et al.
Publicado: (2019)

Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age
por: de Medeiros, Sebastião Freitas, et al.
Publicado: (2019)

Surgical Treatment after Failed Primary Correction of Urogenital Sinus in Female Patients with Virilizing Congenital Adrenal Hyperplasia: Are Good Results Possible?
por: Sircili, Maria Helena Palma, et al.
Publicado: (2016)

Polycystic Ovary Syndrome and Psychotic Disorder
por: Doretto, Larissa, et al.
Publicado: (2020)

Long-term follow-up of a female with congenital adrenal hyperplasia due to P450-oxidoreductase deficiency
por: Bonamichi, Beatriz D. S. F., et al.
Publicado: (2016)

Modulatory effect of BclI GR gene polymorphisms on the obesity phenotype in Brazilian patients with Cushing's disease
por: Moreira, Ricardo P. P., et al.
Publicado: (2013)

Hair cortisol in polycystic ovary syndrome
por: Gonzalez, D., et al.
Publicado: (2022)

Effects of Pre and Post-Natal Androgen Exposure on Psychosexual Aspects and Gender Change in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
por: Batista, Rafael Loch, et al.
Publicado: (2021)

Features of Polycystic Ovary Syndrome in adolescence
por: Tsikouras, P, et al.
Publicado: (2015)

PSAT072 Clinical Features of Patients with 21-Hydroxylase Deficiency and Testicular Adrenal Rest Tumors
por: Bachega, Tânia A S S, et al.
Publicado: (2022)

Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
por: Batista, José Gomes, et al.
Publicado: (2012)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Cutaneous manifestation of polycystic ovary syndrome
por: Abusailik, Mohammad A., et al.
Publicado: (2021)

Immune Dysfunction in Polycystic Ovary Syndrome
por: Banerjee, Soma, et al.
Publicado: (2023)

Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer
por: Shafiee, Mohamad Nasir, et al.
Publicado: (2020)

Recent advances in the understanding and management of polycystic ovary syndrome
por: Rocha, Ana L., et al.
Publicado: (2019)

Hepcidin levels in diabetes mellitus and polycystic ovary syndrome
por: Sam, A H, et al.
Publicado: (2013)

Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
por: Rizk, Maryan G, et al.
Publicado: (2020)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Epidemiology, diagnosis, and management of polycystic ovary syndrome
por: Sirmans, Susan M, et al.
Publicado: (2013)

Exercise and reproductive function in polycystic ovary syndrome: protocol of a systematic review
por: dos Santos, Isis Kelly, et al.
Publicado: (2017)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c5gg5vvgj1b0h2jir1vcovr43k